I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Comparison of iguratimod and conventional cyclophosphamide ..:
Qingran Yan
;
Fang Du
;
Yuening Kang
...
https://doi.org/10.1186/s13063-021-05475-3. , 2021
Link:
https://doi.org/10.1186/s13063-021-05475-3
RT Journal T1
Comparison of iguratimod and conventional cyclophosphamide with sequential azathioprine as treatment of active lupus nephritis: study protocol for a multi-center, randomized, controlled clinical trial (iGeLU study)
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:b9977c4102ed44aa84f61d8564ec0c1e&Exemplar=1&LAN=DE A1 Qingran Yan A1 Fang Du A1 Yuening Kang A1 Ping Ye A1 Xiaodong Wang A1 Jianhua Xu A1 Jianping Tang A1 Niansong Wang A1 Gengru Jiang A1 Zhijun Li A1 Xuan Wang A1 Qin Xue A1 Xinfang Huang A1 Xiaoyan Zhang A1 Ying Zhou A1 Min Dai A1 Chunde Bao PB BMC YR 2021 K1 Systemic lupus erythematosus K1 Active lupus nephritis K1 Randomized clinical trial K1 Iguratimod K1 Cyclophosphamide K1 treatment K1 Medicine (General) K1 R5-920 JF https://doi.org/10.1186/s13063-021-05475-3 LK http://dx.doi.org/https://doi.org/10.1186/s13063-021-05475-3 DO https://doi.org/10.1186/s13063-021-05475-3 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)